Cash Flow Amedisys, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
86.00
39.00
160.00
280.00
210.00
170.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
39.00
-63.00
-105.00
-131.00
26.00
-31.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
221.00
137.00
133.00
188.00
288.00
202.00
Cash Flow from Investing Activities
-6.00
35.00
-85.00
-281.00
-287.00
-352.00
Cash Flow from Financing Activities
-51.00
-88.00
-39.00
54.00
-14.00
227.00
Net Cash Inflow / Outflow
164.00
84.00
8.00
-37.00
-13.00
76.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Amedisys, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
86.216
-435.089
521.00
119.82%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
39.895
-60.862
99.00
165.55%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
221.665
-239.858
460.00
192.42%
Cash Flow from Investing Activities
-6.152
-261.308
255.00
97.65%
Cash Flow from Financing Activities
-51.134
-0.996
-51.00
-5033.94%
Net Cash Inflow / Outflow
164.379
-503.932
667.00
132.62%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-1.77
1.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 61.58% vs 2.93% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
221.66
137.19
61.58%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
